Question 1

Has Neil Niren received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $573,891 in general payments to Neil Niren across 685 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Neil Niren did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Neil Niren come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Janssen Scientific Affairs, LLC	281	$361,202
Novartis	90	$86,277
Johnson & Johnson(2 entities)	71	$54,179
Bristol Myers Squibb	34	$30,116
Amgen	32	$29,618
Almirall LLC	6	$6,066
Sun Pharmaceutical Industries Inc.	8	$1,677
Galderma Laboratories, L.p.	6	$1,281
VYNE Pharmaceuticals Inc.	21	$1,006
Journey Medical Corporation	34	$761
Ortho Dermatologics, A Division Of Bausch Health US, LLC	15	$411
Mayne Pharma Commercial LLC	46	$373
Prugen, Inc. Pharmaceuticals	27	$346
AbbVie	3	$269
Revance Therapeutics, Inc.	2	$71
Incyte Corporation	2	$69
E.r. Squibb & Sons, L.L.C.	1	$48
Sandoz	2	$43
UCB, Inc.	1	$43
Sanofi	2	$27
Biofrontera Inc.	1	$8

Neil Niren

Payments from drug & device makers

Who reported the general payments

How this compares

Other dermatology in Pittsburgh